Lantheus Medcl Drug Patent Portfolio
Lantheus Medcl owns 4 orange book drugs protected by 23 US patents Given below is the list of Lantheus Medcl's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10588988 | Methods and devices for preparation of ultrasound contrast agents | 04 May, 2037 | Active |
| US10583208 | Methods for making ultrasound contrast agents | 16 Mar, 2037 | Active |
| US11266750 | Methods for making ultrasound contrast agents | 16 Mar, 2037 | Active |
| US11529431 | Methods for making ultrasound contrast agents | 16 Mar, 2037 | Active |
| US11857646 | Methods for making ultrasound contrast agents | 16 Mar, 2037 | Active |
| US11925695 | Methods for making ultrasound contrast agents | 16 Mar, 2037 | Active |
| US9789210 | Methods for making ultrasound contrast agents | 16 Mar, 2037 | Active |
| US10583207 | Lipid-encapsulated gas microsphere compositions and related methods | 28 Dec, 2035 | Active |
| US10022460 | Lipid-encapsulated gas microsphere compositions and related methods | 28 Dec, 2035 | Active |
| US11395856 | Lipid-encapsulated gas microsphere compositions and related methods | 28 Dec, 2035 | Active |
| US6676929 | Diagnostic imaging contrast agents with extended blood retention | 04 May, 2020 | Expired |
| US8658205 | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend | 18 Jun, 2019 | Expired |
| US8685441 | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend | 13 Jan, 2019 | Expired |
| US9545457 | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend | 13 Jan, 2019 | Expired |
| US6033645 | Methods for diagnostic imaging by regulating the administration rate of a contrast agent | 19 Jun, 2016 | Expired |
| US7060250 | Diagnostic imaging contrast agents with extended blood retention | 26 May, 2015 | Expired |
| US7229606 | Diagnostic imaging contrast agents with extended blood retention | 26 May, 2015 | Expired |
| US8017105 | Diagnostic imaging contrast agents with extended blood retention | 26 May, 2015 | Expired |
| US5527521 | Low density microspheres and suspensions and their use as contrast agents for computed tomography and in other applications | 22 Feb, 2015 | Expired |
| US7011815 | Diagnostic imaging contrast agents with extended blood retention | 01 Feb, 2015 | Expired |
| US8394356 | Diagnostic imaging contrast agents with extended blood retention | 01 Feb, 2015 | Expired |
| US5585112 | Method of preparing gas and gaseous precursor-filled microspheres | 17 Dec, 2013 | Expired |
| US5431900 | Ester-substituted diaminedithiols and radiolabeled complexes thereof | 11 Jul, 2012 | Expired |
Latest Legal Activities on Lantheus Medcl's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Lantheus Medcl.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Recordation of Patent Grant Mailed
Critical
| 12 Mar, 2024 | US11925695 |
| Recordation of Patent eGrant | 12 Mar, 2024 | US11925695 |
| Mail Patent eGrant Notification | 12 Mar, 2024 | US11925695 |
|
Recordation of Patent Grant Mailed
Critical
| 12 Mar, 2024 | US11925695 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 12 Mar, 2024 | US11925695 |
| Patent eGrant Notification | 12 Mar, 2024 | US11925695 |
|
Email Notification
Critical
| 12 Mar, 2024 | US11925695 |
| Patent eGrant Notification | 12 Mar, 2024 | US11925695 |
|
Email Notification
Critical
| 12 Mar, 2024 | US11925695 |
| Recordation of Patent eGrant | 12 Mar, 2024 | US11925695 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 12 Mar, 2024 | US11925695 |
| Mail Patent eGrant Notification | 12 Mar, 2024 | US11925695 |
|
Email Notification
Critical
| 22 Feb, 2024 | US11925695 |
|
Email Notification
Critical
| 22 Feb, 2024 | US11925695 |
|
Issue Notification Mailed
Critical
| 21 Feb, 2024 | US11925695 |
Lantheus Medcl's Family Patents
Lantheus Medcl drugs have patent protection in a total of 17 countries. It's US patent count contributes only to 32.1% of its total global patent coverage. Click
below to unlock the full patent family tree.
Lantheus Medcl Drug List
Given below is the complete list of Lantheus Medcl's drugs and the patents protecting them.
1. Ablavar
Ablavar is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6676929 | Diagnostic imaging contrast agents with extended blood retention |
04 May, 2020
(4 years ago)
| Expired |
| US7060250 | Diagnostic imaging contrast agents with extended blood retention |
26 May, 2015
(9 years ago)
| Expired |
| US7229606 | Diagnostic imaging contrast agents with extended blood retention |
26 May, 2015
(9 years ago)
| Expired |
| US8017105 | Diagnostic imaging contrast agents with extended blood retention |
26 May, 2015
(9 years ago)
| Expired |
| US7011815 | Diagnostic imaging contrast agents with extended blood retention |
01 Feb, 2015
(9 years ago)
| Expired |
| US8394356 | Diagnostic imaging contrast agents with extended blood retention |
01 Feb, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ablavar's drug page
2. Definity
Definity is protected by 14 patents, out of which 6 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10588988 | Methods and devices for preparation of ultrasound contrast agents |
04 May, 2037
(12 years from now)
| Active |
| US10583208 | Methods for making ultrasound contrast agents |
16 Mar, 2037
(12 years from now)
| Active |
| US11266750 | Methods for making ultrasound contrast agents |
16 Mar, 2037
(12 years from now)
| Active |
| US11529431 | Methods for making ultrasound contrast agents |
16 Mar, 2037
(12 years from now)
| Active |
| US11857646 | Methods for making ultrasound contrast agents |
16 Mar, 2037
(12 years from now)
| Active |
| US11925695 | Methods for making ultrasound contrast agents |
16 Mar, 2037
(12 years from now)
| Active |
| US9789210 | Methods for making ultrasound contrast agents |
16 Mar, 2037
(12 years from now)
| Active |
| US10583207 | Lipid-encapsulated gas microsphere compositions and related methods |
28 Dec, 2035
(11 years from now)
| Active |
| US8658205 | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
18 Jun, 2019
(5 years ago)
| Expired |
| US8685441 | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
13 Jan, 2019
(5 years ago)
| Expired |
| US9545457 | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
13 Jan, 2019
(5 years ago)
| Expired |
| US6033645 | Methods for diagnostic imaging by regulating the administration rate of a contrast agent |
19 Jun, 2016
(8 years ago)
| Expired |
| US5527521 | Low density microspheres and suspensions and their use as contrast agents for computed tomography and in other applications |
22 Feb, 2015
(9 years ago)
| Expired |
| US5585112 | Method of preparing gas and gaseous precursor-filled microspheres |
17 Dec, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Definity's drug page
3. Definity Rt
Definity Rt is protected by 10 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10588988 | Methods and devices for preparation of ultrasound contrast agents |
04 May, 2037
(12 years from now)
| Active |
| US10583208 | Methods for making ultrasound contrast agents |
16 Mar, 2037
(12 years from now)
| Active |
| US11266750 | Methods for making ultrasound contrast agents |
16 Mar, 2037
(12 years from now)
| Active |
| US11529431 | Methods for making ultrasound contrast agents |
16 Mar, 2037
(12 years from now)
| Active |
| US11857646 | Methods for making ultrasound contrast agents |
16 Mar, 2037
(12 years from now)
| Active |
| US11925695 | Methods for making ultrasound contrast agents |
16 Mar, 2037
(12 years from now)
| Active |
| US9789210 | Methods for making ultrasound contrast agents |
16 Mar, 2037
(12 years from now)
| Active |
| US10022460 | Lipid-encapsulated gas microsphere compositions and related methods |
28 Dec, 2035
(11 years from now)
| Active |
| US10583207 | Lipid-encapsulated gas microsphere compositions and related methods |
28 Dec, 2035
(11 years from now)
| Active |
| US11395856 | Lipid-encapsulated gas microsphere compositions and related methods |
28 Dec, 2035
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Definity Rt's drug page
4. Neurolite
Neurolite is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5431900 | Ester-substituted diaminedithiols and radiolabeled complexes thereof |
11 Jul, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Neurolite's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List